Cornelia Kolberg-Liedtke

Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial

Cornelia Kolberg-Liedtke, Oleg Gluz, Fred Heinisch et al. · Breast Cancer Research · 2020 · 39 citations · Full text

Medicine, Immunology, Oncology +17

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice

Andreas Schneeweiß, Carsten Denkert, Peter A. Fasching et al. · Geburtshilfe und Frauenheilkunde · 2019 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +16

TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

M. Martín, S.R. Stecklein, Oleg Gluz et al. · Annals of Oncology · 2024 · 27 citations · Full text

Medicine, Bioinformatics, Oncology +16

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Michael Friedrich, Thorsten Kühn, Wolfgang Janni et al. · Geburtshilfe und Frauenheilkunde · 2021 · 25 citations · Full text

Medicine, Oncology, Surgery +17

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Madlen Garke et al. · Breast Cancer Research · 2022 · 23 citations · Full text

Medicine, Immunology, Oncology +12